Compare ONC & KDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONC | KDP |
|---|---|---|
| Founded | 2010 | 1981 |
| Country | Switzerland | United States |
| Employees | 12000 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5B | 37.4B |
| IPO Year | N/A | 2007 |
| Metric | ONC | KDP |
|---|---|---|
| Price | $276.64 | $26.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 17 |
| Target Price | ★ $377.91 | $35.47 |
| AVG Volume (30 Days) | 242.5K | ★ 8.8M |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.39% |
| EPS Growth | N/A | ★ 45.71 |
| EPS | N/A | ★ 1.53 |
| Revenue | N/A | ★ $16,603,000,000.00 |
| Revenue This Year | $759.19 | $59.13 |
| Revenue Next Year | $14.51 | $14.18 |
| P/E Ratio | $614.06 | ★ $17.87 |
| Revenue Growth | N/A | ★ 8.16 |
| 52 Week Low | $196.53 | $25.03 |
| 52 Week High | $385.22 | $36.12 |
| Indicator | ONC | KDP |
|---|---|---|
| Relative Strength Index (RSI) | 28.89 | 34.13 |
| Support Level | $239.25 | $26.33 |
| Resistance Level | $284.51 | $28.38 |
| Average True Range (ATR) | 7.11 | 0.56 |
| MACD | -2.02 | -0.22 |
| Stochastic Oscillator | 1.35 | 3.39 |
BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.
Keurig Dr Pepper was established in 2018 following a merger between Keurig Green Mountain Coffee and Dr Pepper Snapple. The company manufactures and distributes coffee systems (including coffee brewers and single-serve coffee pods) under the Keurig and Green Mountain brands, as well as ready-to-drink beverages including flavored (non-cola) sparkling soft drinks under well-known brands such as Dr Pepper, Snapple, and Canada Dry. The company controls production and route to market for its own brands through in-house manufacturing plants and distribution infrastructure and leverages these facilities to manufacture and distribute for third-party coffee and beverage brands via licensing and partnership agreements. The US and Canada make up 95% of revenue, with the rest from Mexico.